HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atrial natriuretic peptide attenuates ischemia/reperfusion-induced renal injury by reducing neutrophil activation in rats.

Abstract
Activated neutrophils have been implicated in the development of ischemia/reperfusion (I/R)-induced renal failure. Cytokine-induced neutrophil chemoattractant-1 (CINC-1), a major factor in acute inflammation, is responsible for the activation of neutrophils and for neutrophil chemotaxis to sites of injury. Atrial natriuretic peptide (ANP), a hormone synthesized by the cardiac atria, was shown to possess anti-inflammatory potential due to its potency to inhibit the production of inflammatory mediators. We examined whether the human form of ANP attenuates I/R-induced renal injury by reducing neutrophil activation in a rat model. Male Wistar rats weighing 200-240 g were observed for 24 h after reperfusion following 45-min renal ischemia. Rats were intravenously administered alpha-human ANP (alpha-hANP, 0.2 microg/kg/min) beginning immediately after ischemia and continuing for 2 h after reperfusion. CINC-1 and myeloperoxidase (MPO) concentrations were measured to assess activation of the infiltrating neutrophil. Blood urea nitrogen and serum creatinine and urinary N-acetyl beta-d-glucosaminidase (NAG) were measured as indicators of glomerular function and as a specific indicator of proximal tubular function, respectively. alpha-hANP significantly inhibited I/R-induced increases in renal CINC-1 and MPO concentrations. alpha-hANP also reduced I/R-induced increases in the concentrations of blood urea nitrogen and serum creatinine, and improved histopathologic changes, including acute tubular necrosis. These findings indicate that alpha-hANP attenuates I/R-induced acute renal injury, at least in part by reducing neutrophil activation, and may be useful in surgeries, associated with renal ischemia, as well as in renal transplantation.
AuthorsKousuke Chujo, Masaaki Ueki, Takehiko Asaga, Satoshi Taie
JournalThe Tohoku journal of experimental medicine (Tohoku J Exp Med) Vol. 215 Issue 3 Pg. 257-66 (Jul 2008) ISSN: 1349-3329 [Electronic] Japan
PMID18648186 (Publication Type: Journal Article)
Chemical References
  • Chemokine CXCL1
  • Cxcl1 protein, rat
  • Atrial Natriuretic Factor
  • Creatinine
  • Peroxidase
  • Hexosaminidases
Topics
  • Animals
  • Atrial Natriuretic Factor (metabolism)
  • Chemokine CXCL1 (metabolism)
  • Creatinine (metabolism)
  • Hexosaminidases (metabolism)
  • Inflammation
  • Kidney (injuries, pathology)
  • Male
  • Models, Biological
  • Neutrophil Activation
  • Neutrophils (metabolism)
  • Peroxidase (metabolism)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: